Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 700 participants.

Also called NCT01848171

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 700 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01848171
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01848171. Randomized; no masking; primary purpose treatment. Start 2013-07 (registry gives no type); primary completion 2023-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism
Condition
Hypothyroidism
Condition
Thyroid Diseases
Condition
Endocrine System Diseases
Intervention (Drug)
L-thyroxine
Lead sponsor
Shandong Provincial Hospital (class: other government)

Record details

Record id
cardio:ct-nct01848171
Content hash
d0ffc1ed6a4aa131b73ab8d729d6861c9d6b3d3369238b65518744d73e93e404